AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,049.587

-12.005-1.13%

Number of Gainers:7

Number of Losers:11

Number of Flat:14

PE:- -

High:1,061.859

Open:1,061.825

Low:1,046.234

Close:1,061.591

Loading ...

BRIEF-Dimerix Receives Initial Upfront Payment From FUSO

BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement

CSL Ltd - CSL Seqirus & Esperion Sign Licensing Agreement to Commercialise Nexletol and Nexlizetin Australia & New Zealand

THOMSON REUTERS

Dimerix posts modest gain as first Japanese payment for DMX-200 lands

The Market Herald

Dimerix Ltd - Dimerix Receives Initial Upfront Payment From Fuso

THOMSON REUTERS

LARK Distilling (ASX:LRK) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

Coles Group (ASX:COL) Is Paying Out A Larger Dividend Than Last Year

Simply Wall St.

2 strong ASX 200 blue chip shares for your SMSF

Eucalyptus says weight loss drugs sales are booming

The Australian Financial Review

Ansell Expands Portfolio to Include Kimtech, KleenGuard and RightCycle Brands in North America and Europe

Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why

Leading brokers name 3 ASX shares to buy today

Why this ASX 200 stock could be one of the best to buy in the Asia-Pacific

Arcadium Lithium to be Delisted From ASX 200 Index

MT Newswires Live

Coles Bull Feels Confident It's Outpacing Woolworths -- Market Talk

5 high-quality ASX ETFs to buy in March

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":1049.5869,"timestamp":1741150799920,"preClose":1061.5914,"halted":0,"volume":29593115,"delay":0,"changeRate":-0.011308,"change":-12.004517,"amount":321857115,"amplitude":0.014718,"prevYearClose":1117.913,"fiveDayClose":1069.481,"twentyDayClose":1074.772,"turnoverRate":0.002218,"marketCap":270395422077.5,"floatMarketCap":219684911231.71094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":1061.859,"amplitude":0.014718,"preClose":1061.5914,"low":1046.2341,"latestPrice":1049.5869,"volume":29593115,"delay":0,"open":1061.8245,"prevYearClose":1117.913,"prevWeekClose":1053.164,"prevMonthClose":1053.164,"prevQuarterClose":1117.913,"fiveDayClose":1069.481,"twentyDayClose":1074.772,"sixtyDayClose":1108.058,"secType":"PLATE","market":"AU","turnoverRate":0.002218,"marketCap":270395422077.5,"floatMarketCap":219684911231.71094,"timestamp":1741150799920,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":7,"down":11,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516269987","title":"BRIEF-Dimerix Receives Initial Upfront Payment From FUSO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516269987","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516269987?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:23","pubTimestamp":1741051414,"startTime":"0","endTime":"0","summary":"BRIEF-Dimerix Receives Initial Upfront Payment From FUSOMarch 4  - Dimerix Ltd DXB.AX:RECEIVED UPFRONT PAYMENT OF 300 MILLION FROM FUSO PHARMACEUTICAL INDUSTRIESDIMERIX RECEIVES INITIAL UPFRONT PAYMENT FROM FUSOANTICIPATES A FURTHER 400 MILLION FROM FUSOFurther company coverage: DXB.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM0YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","DXB.AU","BK7067"],"gpt_icon":0},{"id":"2516696895","title":"BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2516696895","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516696895?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:01","pubTimestamp":1741050092,"startTime":"0","endTime":"0","summary":"BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement March 4 (Reuters) - CSL Ltd CSL.AX:CSL SEQIRUS & ESPERION SIGN LICENSING AGREEMENT TO COMMERCIALISE NEXLETOL AND NEXLIZET IN AUSTRALIA & NEW ZEALANDFurther company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2516695406","title":"CSL Ltd - CSL Seqirus & Esperion Sign Licensing Agreement to Commercialise Nexletol and Nexlizetin Australia & New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2516695406","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516695406?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:54","pubTimestamp":1741049681,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7511","CSL.AU","BK7067","BK7501"],"gpt_icon":0},{"id":"2516692168","title":"Dimerix posts modest gain as first Japanese payment for DMX-200 lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2516692168","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516692168?lang=en_us&edition=fundamental","pubTime":"2025-03-04 07:46","pubTimestamp":1741045560,"startTime":"0","endTime":"0","summary":"Dimerix Ltd  has confirmed its receipt of its first $3.2 million payment from Japan’s FUSO Pharmaceutical Industries as part of a deal struck in January.Under that deal, FUSO and Dimerix teamed up to develop and commercialise Dimerix’s drug ‘DMX-200’ in Japan, which treats Focal Segmental Glomerulosclerosis , a scar tissue disease affecting kidneys.The $3.2M upfront payment is the first of multiple Dimerix expects, with up to $30M in payments possible under the FUSO deal. Another $4.1M is expected in the next six to 12 weeks as the first clinical trial in Japan begins.That timeframe is based on the certainty FUSO is already identifying trial sites ahead of the ‘ACTION3’ trial. Notably, FUSO is also responsible for all trial costs.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/dimerix-posts-modest-gain-as-first-japanese-payment-for-dmx-200-lands-2025-03-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7508","DXB.AU","FSGS","BK7501","BK7067","DMX"],"gpt_icon":0},{"id":"2516666705","title":"Dimerix Ltd - Dimerix Receives Initial Upfront Payment From Fuso","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666705?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:33","pubTimestamp":1741037617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0YV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","DXB.AU","BK7067","BK7501"],"gpt_icon":0},{"id":"2516691336","title":"LARK Distilling (ASX:LRK) Is In A Good Position To Deliver On Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2516691336","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516691336?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:07","pubTimestamp":1741036039,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.So should LARK Distilling  shareholders be worried about its cash burn?In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lark-distilling-asx-lrk-good-210719175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LARK","BK7501","BK4211","BK7097","LRK.AU"],"gpt_icon":0},{"id":"2516656126","title":"Coles Group (ASX:COL) Is Paying Out A Larger Dividend Than Last Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656126?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:29","pubTimestamp":1741033764,"startTime":"0","endTime":"0","summary":"Coles Group Limited's  periodic dividend will be increasing on the 27th of March to A$0.37, with investors receiving 2.8% more than last year's A$0.36. Based on this payment, the dividend yield for the company will be 3.4%, which is fairly typical for the industry.Coles Group's Future Dividend Projections Appear Well Covered By Earnings. While it is always good to see a solid dividend yield, we should also consider whether the payment is feasible. Prior to this announcement, Coles Group's dividend was making up a very large proportion of earnings and perhaps more concerning was that it was 135% of cash flows. Paying out such a high proportion of cash flows certainly exposes the company to cutting the dividend if cash flows were to reduce.The next year is set to see EPS grow by 21.3%. If the dividend continues along recent trends, we estimate the payout ratio will be 73%, which would make us comfortable with the sustainability of the dividend, despite the levels currently being quite hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coles-group-asx-col-paying-202924938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7501","BK7082","BK7040","COL.AU"],"gpt_icon":0},{"id":"2516775657","title":"2 strong ASX 200 blue chip shares for your SMSF","url":"https://stock-news.laohu8.com/highlight/detail?id=2516775657","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516775657?lang=en_us&edition=fundamental","pubTime":"2025-03-04 02:37","pubTimestamp":1741027020,"startTime":"0","endTime":"0","summary":"If you are on the hunt for new additions to your self-managed super fund (SMSF), then it could pay to listen to what analysts at Bell Potter are saying about the shares in this article. The broker has","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/04/2-strong-asx-200-blue-chip-shares-for-your-smsf/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL.AU","BK7508","BK7511","BK7044","BK7067","BK7501","JHX.AU"],"gpt_icon":0},{"id":"2516681304","title":"Eucalyptus says weight loss drugs sales are booming","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681304","media":"The Australian Financial Review","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516681304?lang=en_us&edition=fundamental","pubTime":"2025-03-03 16:31","pubTimestamp":1740990660,"startTime":"0","endTime":"0","summary":"Woolworths-backed telehealth start-up Eucalyptus has made around $200 million in the past 18 months selling weight-loss services and drugs such as Wegovy, and plans to revive its mothballed men’s longevity service in Britain.Eucalyptus has become the largest online weight-loss medication company in the country since it was founded in 2019. Investors including Blackbird Ventures, Woolworths’ venture capital arm and Mary Meeker’s Bond Capital have poured in about $150 million to valueit at $560 million.Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/technology/eucalyptus-says-weight-loss-drugs-sales-are-booming-20250303-p5lgdw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK7040","BK7511","BK7501","WOW.AU"],"gpt_icon":0},{"id":"2516557433","title":"Ansell Expands Portfolio to Include Kimtech, KleenGuard and RightCycle Brands in North America and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2516557433","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516557433?lang=en_us&edition=fundamental","pubTime":"2025-03-03 13:00","pubTimestamp":1740978000,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, March 03, 2025----Ansell Limited , a global leader in protection solutions, announced today that its sales organisation will begin accepting Kimtech and KleenGuard orders and managing customer inquiries across North America and Europe. This marks the first significant commercial milestone following the strategic acquisition of Kimberly-Clark's Personal Protective Equipment  business last year and strengthens Ansell’s position as a global leader in safety solutions.With the addition of Kimtech and KleenGuard to Ansell’s market-leading portfolio of brands, Ansell offers an even broader range safety solutions to customers operating in laboratories, cleanrooms, and industrial manufacturing environments.Neil Salmon, CEO of Ansell, stated: \"Ansell’s strategic acquisition of Kimberly-Clark Corporation’s Personal Protective Equipment  business last year not only enhanced the breadth of our portfolio to include best-in-class brands like Kimtech, KleenGuard, and RightCycle,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ansell-expands-portfolio-kimtech-kleenguard-050000182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["PPE.AU","BK7057","BK7126","BK7501","ANN.AU"],"gpt_icon":0},{"id":"2516574632","title":"Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why","url":"https://stock-news.laohu8.com/highlight/detail?id=2516574632","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516574632?lang=en_us&edition=fundamental","pubTime":"2025-03-03 09:10","pubTimestamp":1740964200,"startTime":"0","endTime":"0","summary":"The Mesoblast Ltd  share price is racing higher today. Again. Shares in the  S&P/ASX 300 Index  clinical-stage biotechnology company closed on Friday trading for $2.52. In earlier trade, shares were up 8.3% at $2.73 each. That saw the stock up an eye-popping 810% since this time last year. Or enough to turn an $8,000 investment into $72,800. In just 12 months. After some likely profit-taking, the Mesoblast share price is currently trading at $2.65, up 5.2%.  Here's what's grabbing ASX 200 investor interest today. Mesoblast share price benefits from its own success The ASX 200 biotech stock appears to be garnering additional tailwinds today generated by its own lengthy run higher. You see, with the Mesoblast share price having roared from 30 cents a share 12 months ago to $2.65 today, the company's market cap has surged to $3.4 billion. Why is that important?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/up-810-in-a-year-the-mesoblast-share-price-is-surging-again-on-monday-heres-why/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LTM.AU","MSB.AU","A200.AU","BK7508","BK7507","MESO","BK7501","BK7067","BK7511","BK7095","BK4139","RIO.AU","BK7036","IOZ.AU","XKO.AU"],"gpt_icon":0},{"id":"2516788345","title":"Leading brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2516788345","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516788345?lang=en_us&edition=fundamental","pubTime":"2025-03-03 08:54","pubTimestamp":1740963259,"startTime":"0","endTime":"0","summary":"With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/leading-brokers-name-3-asx-shares-to-buy-today-3-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4023","LU1868836757.USD","IE00B19Z3B42.SGD","LIF","LU0061475181.USD","LU2750360641.GBP","LU2237443549.SGD","BK7078","BK7501","LU2471134796.USD","BK4585","BK7016","BK4127","IE0004086264.USD","BK4516","LU2237443895.HKD","BK4550","LU2237438978.USD","LU2750360997.AUD","BK4533","RMD.AU","LNW.AU","LU1868837136.USD","LU2471134879.HKD","LU1868837300.USD","BK7007","LU0096364046.USD","LU1791807156.HKD","BK4552","LU2237443382.USD","IE0002270589.USD","360.AU","IE0034235188.USD","IE00BFXG1179.USD","LU1868836914.USD","BK4588","BK4504","LU2237443978.SGD","IE0004091025.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU2237443465.HKD","LU1668664300.SGD","LU2471134523.USD","LU2471134952.CNY","LU2237443622.USD","LU1868836591.USD","LU0106831901.USD"],"gpt_icon":1},{"id":"2516254746","title":"Why this ASX 200 stock could be one of the best to buy in the Asia-Pacific","url":"https://stock-news.laohu8.com/highlight/detail?id=2516254746","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516254746?lang=en_us&edition=fundamental","pubTime":"2025-03-03 05:54","pubTimestamp":1740952481,"startTime":"0","endTime":"0","summary":"ResMed Inc.  shares have been on form over the past 12 months. During this time, the sleep disorder treatment company's shares have rallied almost 40% higher. The good news for investors is that it may not be too late to buy this high-quality ASX 200 stock according to analysts at Goldman Sachs. In fact, not only does the broker think that outsized returns are on the cards over the next 12 months, but it feels that ResMed could be one of the best shares to buy in the whole Asia-Pacific region. Why is ResMed one of the best ASX 200 stocks to buy?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/why-this-asx-200-stock-could-be-one-of-the-best-to-buy-in-the-asia-pacific-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4550","LU2237443622.USD","BK4588","RMD.AU","IE0004091025.USD","IE0004086264.USD","LU2237443978.SGD","LU2237443895.HKD","LU0096364046.USD","BK4533","IE00BFXG1179.USD","BK4516","LU2750360641.GBP","BK4552","LU2750360997.AUD","LU0106831901.USD","IE0034235188.USD","LU2237438978.USD","LU1868836757.USD","BK7501","LU1868836914.USD","LU1791807156.HKD","IE00B19Z3B42.SGD","IE0002270589.USD","LU2471134523.USD","BK4127","BK7007","IE00B19Z3581.USD","BK4504","LU1668664300.SGD","LU2237443465.HKD","IE00BSNM7G36.USD","BK4585","LU1868837136.USD","LU2471134796.USD","LU1868836591.USD","LU0061475181.USD","LU2471134879.HKD","LU2237443382.USD","LU1868837300.USD","LU2237443549.SGD","LU2471134952.CNY"],"gpt_icon":0},{"id":"2516846547","title":"Arcadium Lithium to be Delisted From ASX 200 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2516846547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516846547?lang=en_us&edition=fundamental","pubTime":"2025-03-03 05:31","pubTimestamp":1740951065,"startTime":"0","endTime":"0","summary":"Arcadium Lithium  will be removed from the S&P/ASX 200 index as the company will be acquired by Rio Tinto , according to a Friday Australian bourse filing.S&P Dow Jones Indices will remove Arcadium Lithium from the S&P/ASX 200 before the opening of trading on March 6 and replace it with Mesoblast , the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLS.AU","BK7508","RIO.AU","BK7067","BK7511","ALTM","BK4144","BK7507","LTM.AU","BK7095","BK7501","MSB.AU","BK7036","BK4109"],"gpt_icon":0},{"id":"2516547814","title":"Coles Bull Feels Confident It's Outpacing Woolworths -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2516547814","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516547814?lang=en_us&edition=fundamental","pubTime":"2025-03-03 05:27","pubTimestamp":1740950820,"startTime":"0","endTime":"0","summary":"2127 GMT - Coles bull UBS says the Aussie grocer has a leg up on its chief rival Woolworths, pointing out that Coles's sales growth of 3.4% to start 2H is ahead of Woolworths's growth of 3.3%. Cost-of-living pressures are prompting consumers to shop more online and seek out more promotions, but UBS tells clients that Coles is managing the shift well, with Coles optimizing promotions and range better than Woolworths. UBS boosts its target price on Coles to A$22.35/share from A$19.50/share, compared to Friday's close of A$19.98/share. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7082","BK7040","WOW.AU","BK7501","COL.AU","BK7511"],"gpt_icon":0},{"id":"2516154781","title":"5 high-quality ASX ETFs to buy in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2516154781","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516154781?lang=en_us&edition=fundamental","pubTime":"2025-03-03 04:24","pubTimestamp":1740947084,"startTime":"0","endTime":"0","summary":"For investors looking to diversify their portfolios and gain exposure to strong-performing sectors or indices, exchange-traded funds (ETFs) can be a great way to do it. That's because ASX ETFs offer a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/5-high-quality-asx-etfs-to-buy-in-march/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4581","IVV","BK7508","ATEC.AU","BK4559","CBA.AU","SSO","BK4585",".SPX","BK4550","OEF","SH","XJO.AU","XAO.AU","FDN","BK7507","ASIA.AU","BK7511","SDS","CSL.AU","BK4534","OEX","UPRO","SPXU","BHP.AU","VOO","WTC.AU","BK7067","BK4588","VAS.AU","BK4504","BK7135","BK7503","MOAT.AU","BK7095","XKO.AU","XRO.AU","ESmain","BK7016","SPY","IVV.AU","BK7501"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":2,"totalSize":141}]}}